Cargando…

Anxiety and Depression: What Do We Know of Neuropeptides?

In modern society, there has been a rising trend of depression and anxiety. This trend heavily impacts the population’s mental health and thus contributes significantly to morbidity and, in the worst case, to suicides. Modern medicine, with many antidepressants and anxiolytics at hand, is still unab...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kupcova, Ida, Danisovic, Lubos, Grgac, Ivan, Harsanyi, Stefan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9405013/ https://www.ncbi.nlm.nih.gov/pubmed/36004833 http://dx.doi.org/10.3390/bs12080262

Ejemplares similares

Selected Biomarkers of Depression: What Are the Effects of Cytokines and Inflammation?
por: Harsanyi, Stefan, et al.
Publicado: (2022)

Effects of the COVID-19 pandemic on mental health, anxiety, and depression
por: Kupcova, Ida, et al.
Publicado: (2023)

Quasicrystals: What do we know? What do we want to know? What can we know?
por: Steurer, Walter
Publicado: (2018)

Vaginal Aging—What We Know and What We Do Not Know
por: Szymański, Jacek K., et al.
Publicado: (2021)

Multimorbidity: What do we know? What should we do?
por: Navickas, Rokas, et al.
Publicado: (2016)

Biogenic Silver Nanoparticles: What We Know and What Do We Need to Know?
por: Rai, Mahendra, et al.
Publicado: (2021)

Identification of Prognostic and Predictive Osteosarcoma Biomarkers
por: Zamborsky, Radoslav, et al.
Publicado: (2019)

Tissue Engineering and Stem Cell Therapy in Neurogenic Bladder Dysfunction: Current and Future Perspectives
por: Topoliova, Katarina, et al.
Publicado: (2023)

What do we know and when do we know it?
por: Nicholls, Anthony
Publicado: (2008)

Presbyopia: What We Do Know and What We Do Not Know in 2022
por: Grzybowski, Andrzej, et al.
Publicado: (2023)

Treating Postpartum Depression: What Do We Know about Brexanolone?
por: Ali, Muneeza, et al.
Publicado: (2021)

Management of T1 Urothelial Carcinoma of the Bladder: What Do We Know and What Do We Need To Know?
por: Gershman, Boris, et al.
Publicado: (2015)

Cerebrospinal fluid circulation: What do we know and how do we know it?
por: Khasawneh, Ahmad H, et al.
Publicado: (2018)

Mechanisms of atrial fibrillation in athletes: what we know and what we do not know
por: Guasch, E., et al.
Publicado: (2018)

The Catecholaldehyde Hypothesis for the Pathogenesis of Catecholaminergic Neurodegeneration: What We Know and What We Do Not Know
por: Goldstein, David S.
Publicado: (2021)

Microbiome in Multiple Sclerosis: Where Are We, What We Know and Do Not Know
por: Boziki, Marina Kleopatra, et al.
Publicado: (2020)

Cardiac Telocytes 16 Years on—What Have We Learned So Far, and How Close Are We to Routine Application of the Knowledge in Cardiovascular Regenerative Medicine?
por: Klein, Martin, et al.
Publicado: (2021)

Depression in maintenance hemodialysis patients: What do we need to know?
por: Li, Yulu, et al.
Publicado: (2023)

Health Statistics in Australia: What We Know and Do Not Know
por: Madden, Richard, et al.
Publicado: (2022)

Equine Crofton Weed (Ageratina spp.) Pneumotoxicity: What Do We Know and What Do We Need to Know?
por: Shapter, Frances Marie, et al.
Publicado: (2023)

Isolated Nocturnal Hypertension: What Do We Know and What Can We Do?
por: Tadic, Marijana, et al.
Publicado: (2020)

Imprinted Genes and Multiple Sclerosis: What Do We Know?
por: Baulina, Natalia, et al.
Publicado: (2021)

Plastic Interactions with Pollutants and Consequences to Aquatic Ecosystems: What We Know and What We Do Not Know
por: Cássio, Fernanda, et al.
Publicado: (2022)

Chikungunya and diabetes, what do we know?
por: de Almeida Barreto, Francisca Kalline, et al.
Publicado: (2018)

Nutrition and Sarcopenia—What Do We Know?
por: Ganapathy, Aravinda, et al.
Publicado: (2020)

What do we know about pseudodementia?
por: Mouta, Salomé, et al.
Publicado: (2023)

The risk of viral transmission in feed: What do we know, what do we do?
por: Dee, Scott A., et al.
Publicado: (2020)

Developmental Dysplasia of Hip: Perspectives in Genetic Screening
por: Zamborsky, Radoslav, et al.
Publicado: (2019)

Developmental Dysplasia of the Hip: A Review of Etiopathogenesis, Risk Factors, and Genetic Aspects
por: Harsanyi, Stefan, et al.
Publicado: (2020)

Transmission of Ebola Viruses: What We Know and What We Do Not Know
por: Osterholm, Michael T., et al.
Publicado: (2015)

Arrhythmic Burden in Cardiac Amyloidosis: What We Know and What We Do Not
por: Argirò, Alessia, et al.
Publicado: (2022)

Dysfunctional breathing: what do we know?
por: Vidotto, Laís Silva, et al.
Publicado: (2019)

Gullo’s syndrome – what do we know?
por: Rycyk, Anna, et al.
Publicado: (2020)

The origin of life: what we know, what we can know and what we will never know
por: Pross, Addy, et al.
Publicado: (2013)

On Contagion: What Do We Know Regarding It
Publicado: (1877)

Evolutionary ecology of Chagas disease; what do we know and what do we need?
por: Flores‐Ferrer, Alheli, et al.
Publicado: (2017)

Biomarkers of Bladder Cancer: Cell-Free DNA, Epigenetic Modifications and Non-Coding RNAs
por: Harsanyi, Stefan, et al.
Publicado: (2022)

What We Know and Do Not Know about Sex and Cardiac Disease
por: Konhilas, John P.
Publicado: (2010)

Osteoporosis and type 2 diabetes mellitus: what do we know, and what we can do?
por: Abdulameer, Shaymaa Abdalwahed, et al.
Publicado: (2012)

The Role of Testosterone in the Elderly: What Do We Know?
por: Barone, Biagio, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ks3k9tatj720sfku5d699lh7d0